Tenoxicam, a non-steroid anti-inflammatory drug, is unable to increase the response rate in patients with chronic hepatitis C treated by alpha interferon.

MLA

Zarski, J. P., et al. “Tenoxicam, a Non-Steroid Anti-Inflammatory Drug, Is Unable to Increase the Response Rate in Patients with Chronic Hepatitis C Treated by Alpha Interferon.” Hepatology (Baltimore, Md.), vol. 27, no. 3, Mar. 1998, pp. 862–67. EBSCOhost, https://doi.org/10.1002/hep.510270332.

APA

Zarski, J. P., Maynard-Muet, M., Chousterman, S., Baud, M., Barnoud, R., Abergel, A., Bacq, Y., Combis, J. M., Causse, X., Tran, A., Oberti, F., Minello, A., Bresson-Hadni, S., Bailly, F., Raabe, J. J., Leroy, V., Hamici, L., Hicham, T., & Girardin, M. F. (1998). Tenoxicam, a non-steroid anti-inflammatory drug, is unable to increase the response rate in patients with chronic hepatitis C treated by alpha interferon. Hepatology (Baltimore, Md.), 27(3), 862–867. https://doi.org/10.1002/hep.510270332

Chicago

Zarski, J P, M Maynard-Muet, S Chousterman, M Baud, R Barnoud, A Abergel, Y Bacq, et al. 1998. “Tenoxicam, a Non-Steroid Anti-Inflammatory Drug, Is Unable to Increase the Response Rate in Patients with Chronic Hepatitis C Treated by Alpha Interferon.” Hepatology (Baltimore, Md.) 27 (3): 862–67. doi:10.1002/hep.510270332.